|
adult learning principles |
16 |
|
collaborative practice |
16 |
|
evaluation |
16 |
|
interprofessional education |
16 |
|
diabetes |
14 |
|
propofol |
12 |
|
antioxidants |
10 |
|
myocardial ischemia injury |
10 |
|
protein kinase cĪ² |
9 |
|
adiponectin |
8 |
|
jak2/stat3 |
8 |
|
pi3k/akt |
8 |
|
remifentanil |
8 |
|
humans |
7 |
|
oxidative stress |
7 |
|
apoptosis |
6 |
|
empathy |
6 |
|
film |
6 |
|
ischemia reperfusion injury |
6 |
|
medical humanities |
6 |
|
reflective thinking |
6 |
|
dexmedetomidine |
5 |
|
diabetes mellitus |
5 |
|
diabetic cardiomyopathy |
5 |
|
glycogen synthase kinase |
5 |
|
heme oxygenase-1 |
5 |
|
hip fractures - surgery |
5 |
|
infarct size |
5 |
|
janus-activated kinase |
5 |
|
left ventricular hypertrophy |
5 |
|
myocardial hypertrophy and dysfunction |
5 |
|
pain |
5 |
|
ruboxistaurin |
5 |
|
signal transducer and activator of transcription 3 |
5 |
|
anaesthesia |
4 |
|
audiovisual aids |
4 |
|
bispectral index (bis) |
4 |
|
cardiology - education |
4 |
|
cardiovascular diseases - metabolism - physiopathology |
4 |
|
caveolin-3 |
4 |
|
clinical outcomes |
4 |
|
clinical pathway |
4 |
|
comprehension |
4 |
|
conscious sedation - methods |
4 |
|
critical pathways - organization and administration |
4 |
|
education, medical, undergraduate |
4 |
|
geriatric hip fracture |
4 |
|
hypnotics and sedatives |
4 |
|
intrathecal morphine |
4 |
|
intravenous: propofol |
4 |
|
length of stay - statistics and numerical data |
4 |
|
midazolam |
4 |
|
molar, third - surgery |
4 |
|
multidisciplinary |
4 |
|
myocardial ischaemia/reperfusion injury |
4 |
|
opioids |
4 |
|
oxygen - metabolism |
4 |
|
patient care team - organization and administration |
4 |
|
patient simulation |
4 |
|
pilot projects |
4 |
|
shock - metabolism - physiopathology |
4 |
|
students, medical |
4 |
|
surgical wound infection - prevention and control |
4 |
|
surveys and questionnaires |
4 |
|
teaching - methods |
4 |
|
total intravenous anaesthesia (tiva) |
4 |
|
acute kidney injury |
3 |
|
acute myocardial infarction |
3 |
|
adenosine |
3 |
|
amygdala |
3 |
|
anaesthesiology |
3 |
|
analgesics, opioid - administration & dosage |
3 |
|
analgesics, opioid - administration and dosage |
3 |
|
analgesics, opioid - metabolism - therapeutic use |
3 |
|
anesthetics |
3 |
|
animal experiment |
3 |
|
animals |
3 |
|
blended learning |
3 |
|
blood transfusion |
3 |
|
cardiac biomarkers |
3 |
|
cardiac protection |
3 |
|
cardioprotection |
3 |
|
cardiovascular agents - administration & dosage |
3 |
|
circulating tumour cells |
3 |
|
cirrhosis |
3 |
|
cognitive dysfunction |
3 |
|
contrast media |
3 |
|
controlled study |
3 |
|
coronary artery bypass graft surgery |
3 |
|
covid-19 |
3 |
|
damage |
3 |
|
disease models, animal |
3 |
|
dose-response relationship, drug |
3 |
|
e-learning |
3 |
|
endovascular procedures |
3 |
|
erythropoiesis |
3 |
|
erythropoietin |
3 |
|
haemoglobin |
3 |
|
heart infarction size |
3 |
|
heart muscle ischemia |
3 |
|
heart-type fatty acid binding protein |
3 |
|
hemodynamics - drug effects |
3 |
|
hepatic ischaemiareperfusion injury |
3 |
|
hip fracture repair |
3 |
|
hypothermia |
3 |
|
ibuprofen |
3 |
|
infant |
3 |
|
infusions, parenteral |
3 |
|
injections, spinal |
3 |
|
ischaemia reperfusion injury |
3 |
|
ischemic postconditioning - methods |
3 |
|
ischemic preconditioning |
3 |
|
ischemic preconditioning, myocardial |
3 |
|
ischemic preconditioning, myocardial - methods |
3 |
|
isoflurane |
3 |
|
isoflurane - therapeutic use |
3 |
|
liver |
3 |
|
liver - blood supply - drug effects - metabolism |
3 |
|
liver diseases - metabolism - prevention and control |
3 |
|
male |
3 |
|
medical sciences |
3 |
|
metastasis prediction |
3 |
|
modernization |
3 |
|
morphine - administration & dosage |
3 |
|
morphine - administration and dosage |
3 |
|
morphine - administration and dosage - metabolism |
3 |
|
myocardial infarction - metabolism - pathology - prevention & control |
3 |
|
myocardial ischemia |
3 |
|
myocardial reperfusion injury |
3 |
|
myocardial reperfusion injury - metabolism - pathology - prevention & control |
3 |
|
myocardial reperfusion injury - prevention and control |
3 |
|
myocardium - pathology |
3 |
|
narcotic antagonists - pharmacology |
3 |
|
neuroinflammation |
3 |
|
nf-Īŗb |
3 |
|
nitric oxide synthase - drug effects - metabolism |
3 |
|
nitrosative stress |
3 |
|
perioperative |
3 |
|
perioperative management |
3 |
|
post-ischemic myocardial injury |
3 |
|
postconditioning |
3 |
|
postoperative cognitive dysfunction |
3 |
|
preconditioning |
3 |
|
propofol - therapeutic use |
3 |
|
protein kinases |
3 |
|
rats |
3 |
|
rats, sprague-dawley |
3 |
|
receptors, opioid - agonists - metabolism |
3 |
|
receptors, opioid - drug effects - physiology |
3 |
|
receptors, opioid, delta - agonists |
3 |
|
receptors, opioid, kappa - agonists |
3 |
|
receptors, opioid, mu - agonists |
3 |
|
receptors, purinergic p1 - metabolism |
3 |
|
remote preconditioning |
3 |
|
sevoflurane |
3 |
|
somatosensory cortex |
3 |
|
spinal opioid receptors |
3 |
|
squamous cell carcinoma |
3 |
|
surgery |
3 |
|
surgical manipulation |
3 |
|
tau |
3 |
|
tau phosphorylation |
3 |
|
tau proteins |
3 |
|
undergraduate medical education |
3 |
|
acute kidney injury - chemically induced - physiopathology - prevention and control |
2 |
|
affective |
2 |
|
alzheimerās disease |
2 |
|
amyloid |
2 |
|
anaesthesia induction |
2 |
|
analgesics opioid, remifentanil |
2 |
|
analgesics, opioid - pharmacology |
2 |
|
analgesics, opioid - therapeutic use |
2 |
|
anesthesia - methods |
2 |
|
anesthetic preconditioning |
2 |
|
animal model |
2 |
|
anterior cingulate cortex |
2 |
|
antioxidants - therapeutic use |
2 |
|
aortic aneurysm, abdominal - surgery |
2 |
|
awareness |
2 |
|
blood pressure - drug effects |
2 |
|
carcinoma, hepatocellular - therapy |
2 |
|
cardiac |
2 |
|
cardiac surgery |
2 |
|
cardiotonic agents |
2 |
|
cardiotonic agents - pharmacology |
2 |
|
cellular events |
2 |
|
cellular senescence |
2 |
|
children |
2 |
|
chronic pain |
2 |
|
clarity |
2 |
|
clinical practices |
2 |
|
clinician on call |
2 |
|
cognitive functions |
2 |
|
cognitive impairment |
2 |
|
cognitive training |
2 |
|
complications, renal |
2 |
|
contrast media - adverse effects |
2 |
|
coronary vessels - physiology |
2 |
|
difficult airway |
2 |
|
dna damage |
2 |
|
effect-site |
2 |
|
endoscopic retrograde cholangiopancreatography |
2 |
|
endovascular procedures - methods - trends |
2 |
|
exercise |
2 |
|
fluid replacement |
2 |
|
fluid therapy - methods |
2 |
|
fluids, i.v. |
2 |
|
functional laterality - physiology |
2 |
|
gene expression regulation - drug effects - physiology |
2 |
|
guideline |
2 |
|
health surveys |
2 |
|
heart rate - drug effects |
2 |
|
heart, coronary occlusion |
2 |
|
heart, ischaemia |
2 |
|
hepatitis |
2 |
|
hippocampus |
2 |
|
hippocampus - metabolism |
2 |
|
human post mortem brain |
2 |
|
hyperalgesia - metabolism |
2 |
|
hypotension |
2 |
|
hypovolaemia |
2 |
|
imaging |
2 |
|
immune response |
2 |
|
incidence |
2 |
|
inflammation |
2 |
|
intravenous anaesthesia |
2 |
|
kidney, failure |
2 |
|
lewy body pathology |
2 |
|
liver neoplasms - therapy |
2 |
|
morphine - pharmacology |
2 |
|
motor activity |
2 |
|
muscle |
2 |
|
myocardial infarction - pathology |
2 |
|
myocardial protection |
2 |
|
myocardial reperfusion injury - drug therapy - pathology |
2 |
|
myocardial reperfusion injury - prevention & control |
2 |
|
naloxone - analogs & derivatives - pharmacology |
2 |
|
neuralgia - metabolism |
2 |
|
neurological disorders |
2 |
|
neuropathic pain |
2 |
|
nf-kappa b - biosynthesis |
2 |
|
nf-kappa b - metabolism |
2 |
|
opioid |
2 |
|
pain, postoperative - epidemiology - etiology - pathology |
2 |
|
peripheral nervous system diseases - complications - metabolism - pathology |
2 |
|
pharmacodynamics |
2 |
|
pharmacokinetics |
2 |
|
physical phenomena |
2 |
|
physics |
2 |
|
piperidines - therapeutic use |
2 |
|
pleiotropic |
2 |
|
post-operative pain |
2 |
|
postoperative complications - chemically induced |
2 |
|
propofol administration |
2 |
|
propofol: administration |
2 |
|
prostatic neoplasms - therapy |
2 |
|
quaternary ammonium compounds - pharmacology |
2 |
|
questionnaires |
2 |
|
rat |
2 |
|
receptors, opioid |
2 |
|
receptors, opioid - agonists |
2 |
|
receptors, opioid, delta - agonists - antagonists and inhibitors |
2 |
|
receptors, opioid, kappa - agonists - antagonists and inhibitors |
2 |
|
resistance exercise |
2 |
|
scoliosis - surgery |
2 |
|
scoliosis surgery |
2 |
|
senescent cells |
2 |
|
senolytic medicine |
2 |
|
senolytics |
2 |
|
sleep deprivation |
2 |
|
somatosensory cortex - metabolism |
2 |
|
spinal cord - metabolism |
2 |
|
statin |
2 |
|
surgical procedures, minimally invasive - methods |
2 |
|
synaptic proteins |
2 |
|
thalamus |
2 |
|
three-dimensional visualization |
2 |
|
tissue clearing |
2 |
|
ultrasonic therapy - methods |
2 |
|
adrenalin blood level |
1 |
|
adult |
1 |
|
aged |
1 |
|
agitation |
1 |
|
anesthesia - adverse effects - methods |
1 |
|
anesthesia, inhalation - methods |
1 |
|
anisodamine |
1 |
|
anticoagulants (medicine) |
1 |
|
astrocytes |
1 |
|
berberine |
1 |
|
blood flow velocity - drug effects - physiology |
1 |
|
blood sampling |
1 |
|
brain - blood supply - drug effects |
1 |
|
brij-grafted-chitosan |
1 |
|
brij-s20 |
1 |
|
bronchial blockers |
1 |
|
child, preschool |
1 |
|
chitosan |
1 |
|
cholecystectomy |
1 |
|
complications |
1 |
|
cystatin c |
1 |
|
data collection |
1 |
|
dezocine |
1 |
|
diabetic kidney disease |
1 |
|
double-lumen tubes |
1 |
|
drug efflux |
1 |
|
emergency medical services |
1 |
|
fracture fixation - adverse effects - contraindications |
1 |
|
gastric insufflation |
1 |
|
general anesthesia |
1 |
|
glomerular filtration rates |
1 |
|
hip fracture |
1 |
|
homeostasis - drug effects - physiology |
1 |
|
hospitals, pediatric |
1 |
|
hyperemia - physiopathology |
1 |
|
hypertension |
1 |
|
injection pain |
1 |
|
intracranial pressure |
1 |
|
jnk |
1 |
|
laparoscopic |
1 |
|
laparoscopic sleeve gastrectomy |
1 |
|
laparoscopy |
1 |
|
laryngeal masks |
1 |
|
lidocaine |
1 |
|
methyl ethers - pharmacology |
1 |
|
methylglyoxal |
1 |
|
morphine |
1 |
|
multimodal antiemetic prophylaxis |
1 |
|
neutrophil gelatinase-associated lipocalin |
1 |
|
nitric oxide |
1 |
|
one-lung ventilation |
1 |
|
opioid receptors |
1 |
|
oral nanocarrier |
1 |
|
osteoporosis |
1 |
|
osteoporotic fractures - surgery |
1 |
|
p-glycoprotein |
1 |
|
perioperative care - methods |
1 |
|
postoperative |
1 |
|
postoperative delirium |
1 |
|
postoperative nausea and vomiting |
1 |
|
preoperative anaesthetic assessment |
1 |
|
remote ischemic preconditioning |
1 |
|
renal ischemia-reperfusion injury |
1 |
|
respiration, artificial |
1 |
|
solubility |
1 |
|
spinal cord |
1 |
|
st36 acupoint |
1 |
|
supraglottic airway devices |
1 |
|
thoracic surgery |
1 |
|
tourniquet |
1 |
|
trenelenburg position |
1 |
|
ultrasonography, doppler, transcranial - methods |
1 |
|
ultrasound |
1 |
